(Q33341938)

English

A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

carcinoma of unknown primary

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Graham Macdonald

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M C Nicolson

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

L M Samuel

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A W Hutcheon

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

F Y Ahmed

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1238-1242

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma of unknown primary site: a phase II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

Taxane-based chemotherapy for patients with carcinoma of unknown primary site.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

A randomized Phase II trial in patients with carcinoma of an unknown primary site

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

Carcinoma of unknown primary site

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

Treatment of patients with cancer of an unknown primary site

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

Metastatic adenocarcinoma of unknown primary site: analysis of 245 patients seen at The Johns Hopkins Hospital from 1965--1979.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

Atypical metastasis from prostate cancer. Clinical utility of the immunoperoxidase technique for prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

Tumors of unknown origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375343

21 June 2018

VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600258

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600258

21 January 2018

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600258

21 January 2018

Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RESPONSE OF PRIMARY UNKNOWN CANCERS TO TREATMENT WITH 5-FLUOROURACIL (NSC-19893)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the patient with adenocarcinoma of unknown origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic and histologic presentations in unknown primary cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unknown primary adenocarcinoma: incidence of overinvestigation and natural history

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of cisplatin for adenocarcinoma of unknown primary site. IKZ/IKO Clinical Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unknown primary tumors metastatic to liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11953879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6600258

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33341938&oldid=2195262937"